Clinical trials
11 active studies led by Aspargo Labs, Inc, of 11 in all
Source: ClinicalTrials.gov, Studies with Aspargo Labs, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Aspargo Labs, Inc in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Aspargo Labs, Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
11 active studies led by Aspargo Labs, Inc, of 11 in all
Source: ClinicalTrials.gov, Studies with Aspargo Labs, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Aspargo Labs, Inc leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Aspargo Labs, Inc or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Aspargo Labs, Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Aspargo Labs, Inc is in.
Stories on the topics Aspargo Labs, Inc works in.
Only about a quarter of testosterone booster products had study data showing they raise testosterone. Sexual…
Read
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read
In 2022 the FDA approved the first pill for severe alopecia areata, which affects more than 300,000 people in…
Read